Evelyn D'An's most recent trade in Renovaro Biosciences Inc was a trade of 19,894 Option to Purchase Common Stock done . Disclosure was reported to the exchange on March 6, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Renovaro Biosciences Inc | Evelyn D'An | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2021 | 19,894 | 19,894 | - | - | Option to Purchase Common Stock |